U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07092007) titled 'NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer' on July 21.
Brief Summary: This is a single-arm, open label, two cohorts, multi-center clinical study to evaluate the safety and efficacy of HPV-16 targeted mRNA vaccine (NWRD09) in HPV-16 related Cervical, vaginal, and vulvar intraepithelial neoplasia (LSIL and HSIL) patients (cohort A) and HPV-16 related cervical cancer patients (cohort B).
Study Start Date: June 05, 2024
Study Type: INTERVENTIONAL
Condition:
Intraepithelial Neoplasia
Cervical Cancer
Intervention:
BIOLOGICAL: NWRD09 administered by intramuscular injection
NWRD09 administered by intramu...